Department of Kidney Transplantation, Necker Hospital, 149 rue de Sèvres, 75015, Paris, USA.
Nephrol Dial Transplant. 2010 Apr;25(4):1321-8. doi: 10.1093/ndt/gfp500. Epub 2009 Sep 22.
Introduction. Recurrence of nephrotic-range proteinuria in patients with idiopathic nephrotic syndrome (INS) and focal and segmental glomerulosclerosis (FSGS) on native kidneys is associated with poor graft survival. Identification of risk factors for recurrence is therefore an important issue. In 2004, Columbia University introduced a histological classification of FSGS that identifies five mutually exclusive variants. In non-transplant patients, the Columbia classification appears to predict the outcome and response to treatment better than clinical characteristics alone. However, the predictive value of this classification to assess the risk of recurrence after transplantation has not been addressed.
We retrospectively studied 77 patients with INS and FSGS on native kidneys who underwent renal transplantation. Of these, 42 recipients experienced recurrence of nephrotic range proteinuria.
At time of recurrence, minimal-change disease (MCD) was the main histological feature. On serial biopsies, the incidence of MCD decreased over time, while the incidence of FSGS variants increased. The variant type observed in the native kidneys was not predictive of either recurrence or type of FSGS seen on the allograft. Patients with complete and sustained remission did not developed FSGS.
In conclusion, the Columbia classification is of no help in predicting recurrence after renal transplantation or histological lesions in the case of recurrence of proteinuria.
介绍。特发性肾病综合征(INS)和局灶节段性肾小球硬化(FSGS)患者的肾病范围蛋白尿复发与移植物存活率差有关。因此,确定复发的危险因素是一个重要问题。2004 年,哥伦比亚大学提出了一种 FSGS 的组织学分类,该分类确定了五个互斥的变体。在非移植患者中,哥伦比亚分类似乎比单独的临床特征更能预测预后和对治疗的反应。然而,尚未探讨该分类评估移植后复发风险的预测价值。
我们回顾性研究了 77 例接受肾移植的原发性 FSGS 伴 INS 患者。其中 42 例患者出现肾病范围蛋白尿复发。
复发时,微小病变性肾病(MCD)是主要的组织学特征。在连续活检中,MCD 的发生率随时间逐渐降低,而 FSGS 变体的发生率逐渐增加。在供体肾脏中观察到的变体类型既不能预测复发,也不能预测移植物中观察到的 FSGS 类型。完全和持续缓解的患者未发生 FSGS。
总之,哥伦比亚分类在预测蛋白尿复发后的复发或复发时的组织学病变方面没有帮助。